Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EMB-09 by EpimAb Biotherapeutics for Endometrial Cancer: Likelihood of Approval
EMB-09 is under clinical development by EpimAb Biotherapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...